Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Marinol potential in Alzheimer's disease patients reported at congress

Aug. 16, 1996

Sandoz announces Exelon pivotal study results

Aug. 16, 1996

NBI-5788 to enter clinical testing for M.S.

Aug. 16, 1996

Myotrophin expanded access program initiated

Aug. 16, 1996

Genetic insights into MS reported

Aug. 16, 1996

Pfizer investigates enantiomeric profiles of citalopram, fluoxetine

Aug. 16, 1996

Lamotrigine, valproate tested in mood disorders

Aug. 16, 1996

Meiji Seika claims bicyclic thiazoles for CNS disorders

Aug. 16, 1996

Allelix describes D4 antagonists for schizophrenia

Aug. 16, 1996

BTS-73947: new D1/D5 antagonist from Knoll

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...